Overview Financials News + Filings Key Docs Charts Ownership
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
|
|
TRINITY BIOTECH PLC (TRIB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
6-K
| Quarterly results |
| 10/06/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 07/10/2023 |
6-K
| Quarterly results |
| 05/08/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 05/01/2023 |
NT 20-F
| Form NT 20-F - Notification of inability to timely file Form 20-F: |
| 05/01/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 04/25/2023 |
6-K
| Quarterly results |
| 04/24/2023 |
6-K
| Quarterly results |
| 03/31/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 03/30/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/27/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 03/27/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 03/23/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/22/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:|
Docs:
|
"6-K",
"Amended and Restated Credit Agreement and Guaranty dated as of among Trinity Biotech, Inc., Fitzgerald Industries International, Inc., Clark Laboratories, Inc. ), Biopool U.S., Inc. ,",
"Exhibit 4.12.1 First Amendment to Warrant Certificate This First Amendment to Warrant Certificate, dated as of February 21, 2023 , is entered into by and among Trinity Biotech PLC, a public limited company organized and existing under the laws of Ireland and Perceptive Credit Holdings III, LP, a Delaware limited partnership . Recitals Whereas, the Company issued to the Holder that certain Warrant To Purchase American Depositary Shares represented by American Depositary Receipts, dated as of January 27, 2022, . Capitalized terms used herein but not otherwise defined herein shall have the meanings ascribed thereto in the Warrant. Whereas, in connection with that certain Amended and Restated Credit Agreement and Guaranty, dated as of February 21, 2023 , by and among Trinity Biotech, Inc., a D...",
"[email protected]" |
|
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/10/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 12/16/2022 |
6-K
| Quarterly results |
| 12/09/2022 |
6-K
| Quarterly results |
| 12/07/2022 |
SC 13D
| MiCo IVD Holdings, LLC reports a 30% stake in Trinity Biotech plc |
| 11/15/2022 |
6-K
| Quarterly results |
| 11/04/2022 |
6-K
| Quarterly results |
| 11/04/2022 |
6-K
| Quarterly results |
| 11/02/2022 |
6-K
| Quarterly results |
| 10/27/2022 |
6-K
| Quarterly results |
| 10/04/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 09/30/2022 |
6-K
| Quarterly results |
| 09/16/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 09/15/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 09/15/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/12/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 09/12/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:|
Docs:
|
"Notice of Annual General Meeting",
"Annual General Meeting of Trinity Biotech plc The board of directors of the Company encloses notice of an annual general meeting of the Company, to be held at the Company’s registered office at IDA Business Park, Bray, Co. Wicklow, Ireland, A98 H5C8, on September 30, 2022 at 10:00am . Business of Annual General Meeting We would like to take this opportunity to provide some additional information in relation to the various items of business which are to be considered at the AGM. Ordinary Business Resolution 1 seeks the approval from shareholders for an increase in the Company’s authorised share capital by the creation of an additional 600,000,000 A ordinary shares of US$0.0109 each, in order to maintain flexibility. Resolution 2 deals with the reappointment of Grant Thornton as statutory au...",
"Notice of Annual General Meeting",
"Annual General Meeting" |
|
| 08/30/2022 |
F-3
| Form F-3 - Registration statement by foreign private issuers: |
| 07/01/2022 |
6-K
| Quarterly results |
|
|
|